June 16, 2023
January 25, 2025
This week’s newsletter included:
-
Denali, Alucent Present to Utah Life Sciences Innovation Caucus
-
Myriad Genetics Announces Research Collaboration to Use Minimal Residual Disease Testing Platform
-
Kuda Therapeutics Success Story Highlighted by Utah Innovation Center
-
Utah Business Announces 2023 CXOs of the Year
-
CancerVax Reports Positive Progress on Kids Cancer Immunotherapy Treatment
-
Purgo Scientific Named as One of 61 Startups in MedTech Accelerator 2023 Cohort
-
Recursion’s Phase 2 Trial for Treatment of Cerebral Cavernous Malformation Has Fully Enrolled
-
Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (Intranasal Carbetocin) for Prader-Willi Syndrome
-
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
-
CSBI Releases 2023 Life Sciences Workforce Trends Report
-
New Report Explores Best Practices in State Bioscience Economic Development
-
Ampleo Offers New Services – Fractional CMO
Recent News
- Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy of Pediatric Excellence
- Seek Labs Unveils BioSeeker™
- Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
- Purgo Scientific Appoints Veteran MedTech Leader as Chief Executive Officer
- Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
- Improving Women’s Health: MobileODT Joins Liger Medical